Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.

Biohealthmatics.com - Search our database for Health Informatics Journals, Healthcare IT Journals, Bioinformatics Journals and Biotechnology Journals.

Sign Up

Biohealthmatics Centers

Home

Jobs Search

Career Center

Networking Center

Company Profiles

Knowledge Center

Industry News

Web Directory

Industry Books

Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.

Wunderink RG, Waterer GW.

Northwestern University Feinberg School of Medicine, 676 North St. Clair, Suite 14-044, Chicago, IL 60611, USA. r-wunderink@northwestern.edu

Publication Date: Tuesday, November 23, 2004

Click here to view MEDLINE citation

More November, 2004 pharmacogenomics journal articles.

Race-based therapeutics.

The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options.

Pharmacogenomics in cancer therapy: is host genome variability important?

Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs.

Summit calls for clear view of deposits in all biobanks.

[P-glycoprotein--a pump of significance for drug response]

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.

Pharmacogenetics of acute lymphoblastic leukemia.

Medication errors in pediatrics-the octopus evading defeat.

[Pharmacogenomics of the growth hormone : polymorphism of the receptor in the front line.]

Genetic predictors of the clinical response to opioid analgesics : clinical utility and future perspectives.

Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.

Attention-deficit hyperactivity disorder (ADHD).

Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.

Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).

Internet based clinical trial protocols -- as applied to a study of warfarin pharmacogenetics.

Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.

Pharmacogenetics and cardiovascular disease management.

In genetic control of disease, does 'race' matter?

Gene expression microarray technologies in the development of new therapeutic agents.

More pharmacogenomics journal articles ...

Last Updated: 7 August 2006.